{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:20Z","timestamp":1792593680950,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>\n                      To determine the effect of delays in initiation of appropriate antifungal therapy from the initial onset of persistent hypotension to the outcome of\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      septic shock.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>A total of 32 academic and community hospitals in Canada, the United States, and Saudi Arabia (July 1989 to June 2018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>\n                      A total of 850 adult patients with culture-positive\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      septic shock.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Out of 850 patients with\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      septic shock, 69.2% patients (589) received appropriate antifungal therapy after the onset of persistent hypotension. A strong relationship was observed between the delay in initiation of pathogen-appropriate antifungal (PAA) therapy and hospital survival. The adjusted odds ratio of death was 1.045 per hour of delay (95% CI, 1.035\u20131.056;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001). The survival rate was 86% when an appropriate antifungal for the isolated pathogen was administered within 2 hours of the initial documentation of persistent hypotension. Thereafter, hospital survival decreased an average of 5.0% per hour for each hour of delay to 10\u201312 hours of delay. In a multivariate analysis, which included the Acute Physiology and Chronic Health Evaluation II score and epidemiologic\/therapeutic variables, the time to initiation of appropriate antifungal therapy emerged as the single strongest predictor of outcome. Sensitivity analysis further demonstrated that the adverse effects of delayed antifungal treatment were consistent across various subgroups, including different types of infections, pathogens, and antifungal drug classes. Median time to appropriate antifungal therapy was 32.3 hours (interquartile range, 11.2\u201366.0\u2009hr), with only 16.9% receiving therapy within 6 hours of hypotension onset.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Administration of PAAs within the first hours of documented hypotension significantly improved hospital survival. Less than 20% of patients received appropriate antifungals within 6 hours of documented hypotension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007395","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:00:57Z","timestamp":1792591257000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Delay From Hypotension Onset to Appropriate Antifungal Therapy Initiation Is the Critical Determinant of Outcome in Candida Septic Shock"],"prefix":"10.1097","author":[{"given":"Abhinav","family":"Abhishek","sequence":"first","affiliation":[{"name":"Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."},{"name":"Department of Applied Data Sciences, Cleveland State University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Mashhadiagha","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."},{"name":"Department of Applied Data Sciences, Cleveland State University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Ramezani","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."},{"name":"Department of Applied Data Sciences, Cleveland State University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ping","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics, Cleveland State University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Kollef","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Guzman","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem","family":"Kumar","sequence":"additional","affiliation":[{"name":"Biomolecular Sciences Program, Laurentian University, Sudbury, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoanna","family":"Skrobik","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, McGill University, Montreal, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Parrillo","sequence":"additional","affiliation":[{"name":"Heart and Vascular Hospital, Hackensack University Medical Center, Hackensack Meridian School of Medicine, Hackensack, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravan","family":"Kethireddy","sequence":"additional","affiliation":[{"name":"Department of Applied Data Sciences, Cleveland State University, Cleveland, OH."},{"name":"Department of Critical Care Medicine, Cleveland Clinic Integrated Hospital Institute, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[{"name":"Section of Critical Care Medicine, Health Sciences Centre\/St. Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada."},{"name":"Section of Infectious Diseases, Health Sciences Centre\/St. Boniface Hospital, University of Manitoba, Winnipeg, MB, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"R1-20261021","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals.","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20261021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CLEP.S459600","article-title":"Epidemiology of invasive candidiasis.","volume":"16","author":"Bays","year":"2024","journal-title":"Clin Epidemiol"},{"key":"R3-20261021","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of candidemia in the United States, 2017.","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R4-20261021","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"R5-20261021","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis.","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20261021","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/viru.26187","article-title":"Invasive candidiasis as a cause of sepsis in the critically ill patient.","volume":"5","author":"Delaloye","year":"2014","journal-title":"Virulence"},{"key":"R7-20261021","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a five-fold reduction of survival in human septic shock.","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"key":"R8-20261021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13054-020-2793-y","article-title":"Factors associated with the development of septic shock in patients with candidemia: A post hoc analysis from two prospective cohorts.","volume":"24","author":"Bassetti","year":"2020","journal-title":"Crit Care"},{"key":"R9-20261021","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: Importance of empiric therapy and source control.","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R10-20261021","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MJT.0b013e3181a1afb7","article-title":"The effect of time to antifungal therapy on mortality in candidemia associated septic shock.","volume":"16","author":"Patel","year":"2009","journal-title":"Am J Ther"},{"key":"R11-20261021","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/CCM.0000000000001868","article-title":"Patient and organizational factors associated with delays in antimicrobial therapy for septic shock.","volume":"44","author":"Amaral","year":"2016","journal-title":"Crit Care Med"},{"key":"R12-20261021","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"ACCP\/SCCM consensus conference: Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis.","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"R13-20261021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0196-6553(91)90154-5","article-title":"Definitions of infection for surveillance in long-term care facilities.","volume":"19","author":"McGeer","year":"1991","journal-title":"Am J Infect Control"},{"key":"R14-20261021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988.","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"R15-20261021","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/infdis\/jiaa146","article-title":"A critical analysis of the literature on time-to-antibiotics in suspected sepsis.","volume":"222","author":"Weinberger","year":"2020","journal-title":"J Infect Dis"},{"key":"R16-20261021","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis.","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20261021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-021-03883-0","article-title":"Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: A prospective nationwide multicenter cohort study.","volume":"26","author":"Im","year":"2022","journal-title":"Crit Care"},{"key":"R18-20261021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R19-20261021","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0002-9343(02)01248-2","article-title":"Effects of nosocomial candidemia on outcomes of critically ill patients.","volume":"113","author":"Blot","year":"2002","journal-title":"Am J Med"},{"key":"R20-20261021","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/dkr511","article-title":"Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: Correlation with outcomes.","volume":"67","author":"Grim","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R21-20261021","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/idr17020036","article-title":"Improved sixty-day mortality in candidemia with antifungal treatment within 72 hours of fever onset: A single-center retrospective study in rural Japan.","volume":"17","author":"Hayashi","year":"2025","journal-title":"Infect Dis Rep"},{"key":"R22-20261021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med"},{"key":"R23-20261021","doi-asserted-by":"crossref","first-page":"813871","DOI":"10.1155\/2011\/813871","article-title":"Outcomes of neonatal candidiasis: The impact of delayed initiation of antifungal therapy.","volume":"2011","author":"Cahan","year":"2011","journal-title":"Int J Pediatr"},{"key":"R24-20261021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmi.2014.07.006","article-title":"Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: A potential benefit from infectious disease consultation.","volume":"21","author":"Farmakiotis","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R25-20261021","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.","volume":"68","author":"Garnacho-Montero","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R26-20261021","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jac\/dkq216","article-title":"A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients.","volume":"65","author":"Hsu","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R27-20261021","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3109\/13693780903208256","article-title":"The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection.","volume":"48","author":"Kludze-Forson","year":"2010","journal-title":"Med Mycol"},{"key":"R28-20261021","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/AAC.02088-12","article-title":"Time to initiation of antifungal therapy for neonatal candidiasis.","volume":"57","author":"Le","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20261021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s001340050286","article-title":"Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infection in the ICU.","volume":"23","author":"Nolla-Salas","year":"1997","journal-title":"Intensive Care Med"},{"key":"R30-20261021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40560-020-00450-7","article-title":"Impact of host- and early treatment-related factors on mortality in ICU patients with candidemia: A bicentric retrospective observational study.","volume":"8","author":"Ohki","year":"2020","journal-title":"J Intensive Care"},{"key":"R31-20261021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofac383","article-title":"Key role of early source control in candidemic patients with sepsis or septic shock.","volume":"9","author":"Papadimitriou-Olivgeris","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R32-20261021","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/CCM.0000000000000221","article-title":"Impact of therapeutic strategies on the prognosis of candidemia in the ICU.","volume":"42","author":"Puig-Asensio","year":"2014","journal-title":"Crit Care Med"},{"key":"R33-20261021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13613-020-00755-8","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: A single-center retrospective 10-year analysis.","volume":"10","author":"Schroeder","year":"2020","journal-title":"Ann Intensive Care"},{"key":"R34-20261021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-10-150","article-title":"Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: A retrospective cohort study.","volume":"10","author":"Zilberberg","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R35-20261021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12879-017-2207-1","article-title":"Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: A retrospective analysis from the China-SCAN study.","volume":"17","author":"Cui","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R36-20261021","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality.","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-20261021","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.202309-1636OC","article-title":"Temporal trends in mortality of critically ill patients with sepsis in the United Kingdom, 1988-2019.","volume":"209","author":"Prescott","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-20261021","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000000026","article-title":"Two decades of mortality trends among patients with severe sepsis: A comparative meta-analysis.","volume":"42","author":"Stevenson","year":"2014","journal-title":"Crit Care Med"},{"key":"R39-20261021","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-022-04176-w","article-title":"Trends in mortality in septic patients according to the different organ failure during 15 years.","volume":"26","author":"Lorencio Cardenas","year":"2022","journal-title":"Crit Care"},{"key":"R40-20261021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/viru.26913","article-title":"An alternate pathophysiologic paradigm of sepsis and septic shock: Implications for optimizing antimicrobial therapy.","volume":"5","author":"Kumar","year":"2014","journal-title":"Virulence"},{"key":"R41-20261021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/498909","article-title":"The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: Association with serum lactate and inflammatory cytokine levels.","volume":"193","author":"Kumar","year":"2006","journal-title":"J Infect Dis"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:01:03Z","timestamp":1792591263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007395","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}